SCHEMBL25272437

SCHEMBL25272437

O=C1CCC(N2Cc3c(CN4CCN(c5cccnn5)CC4)cccc3C2=O)C(=O)N1

nearest known ligand 0.60

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 17/20 0.60
▸ IKZF3 Q9UKT9 15/20 0.60
▸ IKZF2 Q9UKS7 2/20 0.53
▸ DDB1 Q16531 3/20 0.53
▸ IKZF1 Q13422 2/20 0.53
▸ TNF P01375 2/20 0.53
▸ IL1B P01584 2/20 0.53
▸ BRD4 O60885 1/20 0.53
▸ CSNK1A1 P48729 1/20 0.51
▸ DRD2 P14416 1/20 0.50
▸ ADRA1D P25100 1/20 0.50
▸ ADRA1A P35348 1/20 0.50
▸ ADRA1B P35368 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31076731 1.00 CRBN (0.60) CRBNIKZF3IKZF2DDB1IKZF1
SCHEMBL25647385 0.88 CRBN (0.58) CRBNIKZF3IKZF2DDB1IKZF1
SCHEMBL31077283 0.84 CRBN (0.72) CRBNIKZF3IKZF2DDB1IKZF1
SCHEMBL25225443 0.84 CRBN (0.72) CRBNIKZF3IKZF2DDB1IKZF1
SCHEMBL30458627 0.84 CRBN (0.49) CRBNIKZF3IKZF2DDB1
SCHEMBL25647383 0.84 CRBN (0.55) CRBNIKZF3DDB1IKZF1TNF
SCHEMBL31077515 0.84 CRBN (0.55) CRBNIKZF3DDB1IKZF1TNF
SCHEMBL25272444 0.83 CRBN (0.71) CRBNIKZF3IKZF2DDB1IKZF1
SCHEMBL31076618 0.83 CRBN (0.71) CRBNIKZF3IKZF2DDB1IKZF1
SCHEMBL25226548 0.82 IKZF2 (0.65) CRBNIKZF3IKZF2IKZF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023104155-A1 LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF 标新生物医药科技(上海)有限公司 2023-06-15 — — WO claimed
CN-116239566-A E3 ubiquitin ligase ligand compound, protein degradation agent developed based on ligand compound and application thereof 标新生物医药科技(上海)有限公司 2023-06-09 — — CN claimed
WO-2023104155-A1 LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF 标新生物医药科技(上海)有限公司 2023-06-15 — — WO disclosed
Send feedback